Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented an analysis from the Phase 2 ...

Your car might start without complaint every morning and sail through its last inspection, but […] ...

It’s easy to blame ballooning budgets on jobsite errors. But project stakeholders need to own decisions earlier in the ...

This overlooked engine part controls everything, and most drivers never think about it.

Deaconess reports a 53% spike in flu cases and a 13% rise in RSV. A local doctor breaks down who's most at risk and what to ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...

“Pre-workout supplements, which often contain high levels of caffeine and stimulant-like ingredients, have become ...

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop a pipeline of next-generation products, today ...

At SheSparks 2026, CK Kumaravel shared how a personal moment inspired Naturals Salon & Spa and his mission to advance women’s ...

Stifel 2026 Virtual CNS Forum March 17, 2026 2:00 PM EDTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Panels for use on the fully automated QIAstat-Dx Rise platform, marking the ninth U.S. QIAstat-Dx panel clearance in last 24 monthsLaboratories can now run respiratory and gastrointestinal panels, ...